Cryoport Inc
NASDAQ:CYRX
Cryoport Inc
Cash Equivalents
Cryoport Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cryoport Inc
NASDAQ:CYRX
|
Cash Equivalents
$5.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
122%
|
CAGR 10-Years
39%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash Equivalents
$1.2B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash Equivalents
$2.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
76%
|
CAGR 10-Years
28%
|
|
Stryker Corp
NYSE:SYK
|
Cash Equivalents
$2.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash Equivalents
$6.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash Equivalents
$2.2B
|
CAGR 3-Years
39%
|
CAGR 5-Years
29%
|
CAGR 10-Years
11%
|
See Also
What is Cryoport Inc's Cash Equivalents?
Cash Equivalents
5.4m
USD
Based on the financial report for Dec 31, 2023, Cryoport Inc's Cash Equivalents amounts to 5.4m USD.
What is Cryoport Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
39%
Over the last year, the Cash Equivalents growth was 198%. The average annual Cash Equivalents growth rates for Cryoport Inc have been -23% over the past three years , 122% over the past five years , and 39% over the past ten years .